Skip to content
MS
rate-limiting unreviewed

Isocitrate dehydrogenase (mitochondrial NAD+-dependent IDH3)

1 reactions · 1 pathways

Clinical / pharmacological. Rate-limiting TCA step; IDH1/2 neomorphic mutations produce 2-hydroxyglutarate in glioma/AML

What it does, reaction by reaction

1 reactions

Citric Acid Cycle (TCA / Krebs Cycle) Energy Metabolism & Cellular Respiration · Mitochondrial matrix

step 3 Irreversible rate-limiting

Isocitrate + NAD+ → oxalosuccinate + NADH + H+; oxalosuccinate → alpha-ketoglutarate + CO2

Converts Isocitrate NAD+ into Oxalosuccinate NADH H+

Notes

Required cofactors: NAD+ and Mg2+ or Mn2+. This is an essentially irreversible, rate-limiting regulatory step of the cycle; the CO2 released in the first turn is not necessarily derived from the newly introduced acetyl carbons.

Showing all 1 reactions.

What accelerates and inhibits it

Regulation is pathway-specific, so each context is listed separately

1 entries

Citric Acid Cycle (TCA / Krebs Cycle)

Listed there as: Isocitrate dehydrogenase (IDH3)

Accelerated by

ADP, Ca2+ in muscle

Inhibited by

ATP, NADH

Hormonal control

Ca2+ released during contraction activates IDH3; hormonal effects are largely indirect through energy demand and substrate supply

Recent literature

Nothing is fetched until you ask, so the page stays fast and the request is yours rather than automatic.

Europe PMC · ten most recent, newest first